Semaglutide Linked to 42% Fewer Psychiatric Hospital Episodes
TL;DR: A 2026 study in The Lancet Psychiatry found that psychiatric hospital visits and sickness absence were lower during semaglutide treatment periods in Swedish registry data. Key Findings 42% lower psychiatric care during semaglutide periods: Psychiatric hospital visits and sickness absence episodes dropped 42% when the same individuals were on semaglutide compared to when they …
